Nitrase Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1000 Marina Blvd Ste 200, Brisbane, Cali...Website
www.nitrasetx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nitrase Therapeutics
Nitrase Therapeutics utilizes its proprietary NITROME Platform to unlock the therapeutic potential of nitrases by identifying novel enzymes, substrates, and their roles in diseases. Their platform enables the elucidation of nitrases' biology and the development of innovative therapeutics for various conditions. Nitrase Therapeutics focuses on pioneering medicines through groundbreaking biology with a primary emphasis on nitrases.Explore more
Nitrase Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nitrase Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Nitrase Therapeutics
Check out if Nitrase Therapeutics is spiking on competitors!
Check if Nitrase Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Nitrase Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Nitrase Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Nitrase Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Nitrase Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Nitrase Therapeutics launches new products
Recommended Actions
Find VP level buyers at Nitrase Therapeutics
Find 3 more new buyers
Compare Similar Companies to Nitrase Therapeutics
Compare insights from companies similar to Nitrase Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nitrase Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nitrase Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nitrase Therapeutics.
Nitrase Therapeutics Tech Stack
A closer look at the technologies used by Nitrase Therapeutics
Nitrase Therapeutics News & Media
Nitrase Therapeutics Unveils Protein with Newly Characterized Enzymatic Function Involved in the Pathogenesis of Parkinson’s Disease
- Glyoxalase Domain-containing Protein 4 (GLOD4), the First Identified in a New Class of Enzymes Called Nitrases, Generates Nitrated Alpha-synuclein, a Hallmark of Parkinson’s Disease (PD)Nitrase Therapeutics Presents Preclinical Data Demonstrating Antibody Prevents Spread of Pathology of Parkinson’s Disease at SfN’s Neuroscience 2024 Scientific Congress
-Development Candidate NDC-0524 is a First-in-Class, Humanized Therapeutic Antibody with High Affinity and Selectivity for Nitrated -Synuclein, which is Rapidly Being Advanced into the Clinic for the Treatment of Parkinson’s DiseaseNitrase Therapeutics Presents Preclinical Data on the Role of Enzymatic Nitration in Oncology at the American Association for Cancer Research Annual Meeting
BRISBANE, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases, a new class of enzymes discovered in-house that are involved in a broad variety of diseases, today announced the company presented preclinical data highlighting nitrases as newly-discovered therapeutic targets for oncology in a poster presentation (abstract #3941) at the 2023 American Association for CanceHitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based Drug Discovery
CHENGDU, China, Dec. 11, 2022 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced that it has entered into a research agreement with Nitrase Therapeutics, Inc. ("Nitrase"), a biopharmaceutical company deploying its NITROME platform...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Nitrase Therapeutics
Sign Up For FreeTo access detailed company insights
Nitrase Therapeutics utilizes its proprietary NITROME Platform to unlock the therapeutic potential of nitrases by identifying novel enzymes, substrates, and their roles in diseases. Their platform enables the elucidation of nitrases' biology and the development of innovative therapeutics for various conditions. Nitrase Therapeutics focuses on pione... Read More
